Consensus on the development of vaccines against naturally acquired melioidosis - Wikidata - wikimedia - TriplyDB

Consensus on the development of vaccines against naturally acquired melioidosis

Consensus on the development of vaccines against naturally acquired melioidosis

http://www.wikidata.org/entity/Q26864912

about

Melioidosis: Clinical impact and public health threat in the tropics.An avirulent Burkholderia pseudomallei ∆purM strain with atypical type B LPS: expansion of the toolkit for biosafe studies of melioidosis.Pulmonary infections in the returned traveller.T-Cell Responses Are Associated with Survival in Acute Melioidosis Patients.Characterization of New Virulence Factors Involved in the Intracellular Growth and Survival of Burkholderia pseudomallei.Barriers and Recommended Interventions to Prevent Melioidosis in Northeast Thailand: A Focus Group Study Using the Behaviour Change Wheel Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice.Structural diversity of Burkholderia pseudomallei lipopolysaccharides affects innate immune signaling.Development of Rapid Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Burkholderia pseudomallei.Cloning, expression, and characterization of a peptidoglycan hydrolase from the Burkholderia pseudomallei phage ST79.Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches.Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory Identification of the Burkholderia pseudomallei bacteriophage ST79 lysis gene cassette.Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Cross Protection against Inhalational Glanders in Mice and Non-Human Primates.Melioidosis: where do we stand in the development of an effective vaccine?Vaccines for the Prevention of Melioidosis and Glanders.Immune Control of Burkholderia pseudomallei--Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes.Melioidosis in Thailand: Present and Future.

P2860

Q33663333-DEC1DF3A-52AB-4ED2-8E5E-83CF3635C7F5 Q33771536-C5497D58-CF5A-476F-9085-018968C615F1 Q33801976-C395AA5E-33F3-4905-BB4E-89BEBD5A324D Q35818580-FE09ED0A-95B4-449E-A8FA-421155C8AAC5 Q35880149-B24EDA52-17D0-44F8-A699-1E89F66E98E5 Q36089629-E1B22E21-805E-4807-A086-D235AAB73BA8 Q36289996-024AD9AA-2FF6-4BD8-9EA0-AC7A15CF531E Q36357954-253707CA-00C0-4E5B-9B3C-BD6C97D96F81 Q36834805-6FD5DC44-E40C-4FE4-B4EE-4F9379B0FA6F Q37260052-6A833E62-6ECD-4EC9-ABB1-D719495229C8 Q38784773-AA595847-0C4D-4C15-AA43-1DC42D583DC4 Q38890754-79FEF25D-A4D2-409C-A89E-9D809B4C9736 Q38961000-7F079F4B-32CF-4599-B9D6-9041C6C04FF1 Q39869789-798589A7-E5BE-400F-98FC-A2F0265ED5D5 Q40286028-796342C3-D9A1-4CC8-BAEE-F09A558460FF Q46242885-7BF406BD-B3BA-42FE-8879-1FC64736ECB9 Q48144660-F4B57ED0-8BC2-48D8-86F5-E1C90F4A1917 Q49834322-9DF909C5-26DD-4C00-AE21-095DFC5B50A5 Q54242408-FADD7441-6CD4-4B14-8607-FE6319C4EE36 Q55069370-CF244AD5-8BE1-4143-A3F2-F66E5BBEDC96

P2860

Consensus on the development of vaccines against naturally acquired melioidosis

http://www.wikidata.org/entity/Q26864912

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Consensus on the development of vaccines against naturally acquired melioidosis

@ast

Consensus on the development of vaccines against naturally acquired melioidosis

@en

Consensus on the development of vaccines against naturally acquired melioidosis

@nl

type

label

Consensus on the development of vaccines against naturally acquired melioidosis

@ast

Consensus on the development of vaccines against naturally acquired melioidosis

@en

Consensus on the development of vaccines against naturally acquired melioidosis

@nl

prefLabel

Consensus on the development of vaccines against naturally acquired melioidosis

@ast

Consensus on the development of vaccines against naturally acquired melioidosis

@en

Consensus on the development of vaccines against naturally acquired melioidosis

@nl

P1433

Q26864912-5EABA29E-5D36-4620-874E-87A640226E83

P1476

Q26864912-C30048CD-079A-4F6E-B749-E8A49483F277

P2093

Q26864912-1D9161AE-9576-4606-9E9F-DFBE3469DB0D

Q26864912-6379F134-6AD3-4B45-A215-D0C6E310175D

Q26864912-665E104F-9FEC-41C1-B28A-38D9E89046D6

Q26864912-86F70927-C793-4DC3-907B-8E1E8F67BD60

Q26864912-88335BA9-BD78-43FE-BE1A-4CD910ACBFF7

Q26864912-D6443DDA-F21F-4543-AAB1-EAF7D1B5DCB5

Q26864912-E0E4CA67-A644-4EFD-BCA1-EB76786F7AD4

P2860

Q26864912-012B2A89-6769-4BD3-A8A1-603B7F3BE859

Q26864912-0A22566E-3BF9-4E42-9012-210E9D6D56E7

Q26864912-23244581-C21D-4F37-B555-B4D2B8DE5063

Q26864912-36D936A0-D2F5-4A08-BE77-E95ED4663DAB

Q26864912-4611CCFC-785D-4A80-B99A-8FFA38BC962E

Q26864912-4A628781-AA23-4394-AC3B-2F5C00C4B1BC

Q26864912-59829C0D-683F-44BF-8645-AEF29F6EC83A

Q26864912-65B9BE3B-1ECC-4F6E-8D41-588E09197240

Q26864912-8E64554D-0D80-4FB7-B314-FD19A11D9ECB

Q26864912-8F19BB15-E742-4338-AC57-8E772BB2AEC5

P31

Q26864912-9A780F8C-AF55-4281-8F36-EA9DFE063DFD

P3181

Q26864912-ABD7CE46-3F15-4BA5-B1B6-C8783E30A227

P356

Q26864912-91F2D882-4AA6-43A1-A1EC-FFDCE1111296

P407

Q26864912-422E1D68-4634-4DA1-90A2-55EF53257B4B

P433

Q26864912-197A60A6-23D3-42D9-B541-4C48BB22D961

P478

Q26864912-D817C5CE-BE3B-4F76-B1EE-BF5EB39EC794

P50

Q26864912-83E7C763-E6AA-4E9D-AAFB-DC77022F27C4

Q26864912-917ACCB3-DAD4-47F4-BF04-B69B179F1C74

Q26864912-94580A60-EE06-4C01-A2F8-90E663B51C06

Q26864912-DB920FFA-FE29-4EE8-9244-4016D3F73EB9

P577

Q26864912-A0E4C091-4044-4DED-9051-58807ED56732

P5875

Q26864912-390DB53D-AF24-4A0C-9AB9-C775E60E85A5

P698

Q26864912-DE3C1786-C990-4A34-80A7-D84100367651

P921

Q26864912-EC856F2D-BD06-4361-8B04-4035F792A976

Q26864912-ED798FA8-1D4B-4AA9-A154-3434D5FD2A44

P932

Q26864912-62A8D017-E7DD-4C68-B920-B84C79E07627

P3181

P356

P1433

Emerging Infectious Diseases

P1476

Consensus on the development of vaccines against naturally acquired melioidosis

@en

P2093

Direk Limmathurotsakul

http://www.w3.org/2001/XMLSchema#string

Gregory Bancroft

http://www.w3.org/2001/XMLSchema#string

Lisa A Morici

http://www.w3.org/2001/XMLSchema#string

Paul J Brett

http://www.w3.org/2001/XMLSchema#string

Sharon J Peacock

http://www.w3.org/2001/XMLSchema#string

Steering Group on Melioidosis Vaccine Development

http://www.w3.org/2001/XMLSchema#string

Timothy Atkins

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing incidence of human melioidosis in Northeast Thailand

An objective approach for Burkholderia pseudomallei strain selection as challenge material for medical countermeasures efficacy testing

Melioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes

Systematic review and consensus guidelines for environmental sampling of Burkholderia pseudomallei

Suggested use of vaccines in diabetes.

Use of influenza and pneumococcal vaccines in people with diabetes.

The PmlI-PmlR quorum-sensing system in Burkholderia pseudomallei plays a key role in virulence and modulates production of the MprA protease.

Model of differential susceptibility to mucosal Burkholderia pseudomallei infection.

A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis.

Development of vaccines against burkholderia pseudomallei.

P31

scholarly article

P3181

3504506

http://www.w3.org/2001/XMLSchema#string

P356

10.3201/EID2106.141480

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Alfredo G Torres

Susanna Dunachie

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276158374

http://www.w3.org/2001/XMLSchema#string

P698

25992835

http://www.w3.org/2001/XMLSchema#string

P921

vaccine development

P932

4451926

http://www.w3.org/2001/XMLSchema#string